RxDoctor Payments Data

Adrian Wiestner

Hematology · Bethesda, MDNPI 1942075114

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 2 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Genmab U.S., Inc.. That places this record below the midpoint for hematology clinicians in MD, where the typical reported total is $129.

$55in general payments, 2019–2025

Across 2 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genmab U.S., Inc.$55
$7,416,425in research payments, 2019–2025

Across 9 payments — averaging $824,047 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pharmacyclics LLC, An Abbvie Company$4.7M
  • AbbVie$2.2M
  • Genmab A/s$530K
  • Merck$70K

What the payments were for

  • Food & beverage$55100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genmab U.S., Inc.2$55

How this compares

$55 in reported general payments places this provider in the 30th percentile of 28 hematology providers in Maryland.

See all hematology providers in Maryland

Other hematology in Bethesda

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →